MAY 30, 2014 07:30 AM PDT
The Role of Lactate in the Risk Assessment of Morbidity and Mortality
Presented at the Clinical Diagnostics and Research Virtual Event
82 50 2554

Speakers:
  • Senior Medical/Clinical Consultant, Siemens Healthcare Diagnostics
    Biography
      Dr. Sayegh received his Bachelor of Science in Biology and Chemistry from the University of Mobile in Mobile, AL, Medical Technology from Anderson Memorial Hospital School of Medical Technology in Anderson, SC, Master of Science in Health Sciences with emphasis on Hematology/Oncology from the American University School of Graduate Studies in Coral Gables, FL and awarded Doctor of Medicine Degree from the American University School of Medicine in Coral Gables, FL. His Post- graduate training is in General Surgery with emphasis on Emergency Non-Trauma Minimally Invasive Laparoscopic Surgery from the University of Southern California in Los Angeles, CA. Dr. Sayegh has over 25 years of experience in the fields of Medicine, Research, Surgery and Clinical Laboratory Science. Background includes extensive Immunology/Allergy, Hematology/Oncology, Endocrinology, Special Chemistry, HLA Histocompatiblity and Maternal screen.  He held key consulting positions focused on multiple disciplines in Medicine , both hospital and reference laboratories. 

    Abstract:
    The value of measuring lactate levels is expanding. Though generally considered a nonspecific biomarker, knowing lactate levels early in a patients presentation can provide valuable information to help guide assessment and treatment. It can be particularly useful in ICU and ED settings where the presentation of symptoms may be inconclusive while diseases progress rapidly with severe pathology. Lactate testing can open a critical window for early intervention when treatment is most likely to be successful. This seminar provides a framework for understanding lactate and the role it can play as a prognostic indicator of morbidity and mortality.

    Seminar Objectives
    At the conclusion of the seminar, attendees should be able to:

    Understand the role of lactate as a prognostic indicator for morbidity and mortality
    Identify disease states where lactate testing can add significant clinical value
    Understand the differences between the systemic inflammatory response (SIR) and sepsis, severe sepsis and septic shock
    Understand the urgency associated with assessing lactate levels

    Show Resources
    Loading Comments...